EcoDrugPlus

Kinase Insert Domain Receptor (A Type Iii Receptor Tyrosine Kinase)

Ensembl ID : ENSAPEG00000015136
Gene Symbol: KDR
1 Cross references
198 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSAPEG00000013934
Gene Symbol: KIF11
1 Cross references
202 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSAPEG00000016669
Gene Symbol: KIF5B
2 Cross references
245 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSAPEG00000003717
Gene Symbol: KIF5B
2 Cross references
243 Possible Orthologues:

Lectin, Galactoside Binding Soluble 3a

Ensembl ID : ENSAPEG00000009372
Gene Symbol: LGALS3A
1 Cross references
220 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSAPEG00000024559
Gene Symbol: LTA4H
1 Cross references
205 Possible Orthologues:

Leukotriene B4 Receptor

Ensembl ID : ENSAPEG00000002033
Gene Symbol: LTB4R
1 Cross references
143 Possible Orthologues:

Leukotriene B4 Receptor 2a

Ensembl ID : ENSAPEG00000002049
Gene Symbol: LTB4R2A
1 Cross references
159 Possible Orthologues:

Leukotriene B4 Receptor 2b

Ensembl ID : ENSAPEG00000020273
Gene Symbol: LTB4R2B
1 Cross references
167 Possible Orthologues:

Lysine (K)-Specific Demethylase 1a

Ensembl ID : ENSAPEG00000017416
Gene Symbol: KDM1A
1 Cross references
214 Possible Orthologues:

Lysyl Oxidase-Like 2a

Ensembl ID : ENSAPEG00000003633
Gene Symbol: LOXL2A
1 Cross references
208 Possible Orthologues:

Lysyl Oxidase-Like 2b

Ensembl ID : ENSAPEG00000018430
Gene Symbol: LOXL2B
1 Cross references
213 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).